
==== Front
Int J Cardiol Heart Vasc
Int J Cardiol Heart Vasc
International Journal of Cardiology. Heart & Vasculature
2352-9067
Elsevier

S2352-9067(24)00166-0
10.1016/j.ijcha.2024.101500
101500
Review
Endoplasmic reticulum stress in abdominal aortic aneurysm
Su Zhaohai ab
Lu Weiling b
Cao Jun b
Xie Zheng c⁎
Zhao Pei zhaopei@yzu.edu.cn
a⁎⁎
a Department of Cardiology, Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu 225001, PR China
b Department of Cardiology, Ganzhou Hospital of Guangdong Provincial People’s Hospital, Ganzhou Municipal Hospital (Gannan Medical University Affiliated Municipal Hospital), Ganzhou, Jiangxi 341000, PR China
c Department of General Practice, Ganzhou Hospital of Guangdong Provincial People’s Hospital, Ganzhou Municipal Hospital (Gannan Medical University Affiliated Municipal Hospital), Ganzhou, Jiangxi 341000, PR China
⁎ Corresponding author.
⁎⁎ Corresponding author at: Department of Cardiology, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368 Hanjiang Middle Road, Yangzhou, Jiangsu 225001, PR China. zhaopei@yzu.edu.cn
29 8 2024
10 2024
29 8 2024
54 10150029 6 2024
20 8 2024
22 8 2024
© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abdominal aortic aneurysms (AAAs) are characterized by permanent dilatation of the abdominal aorta, which is accompanied by inflammation, degradation of the extracellular matrix (ECM) and disruption of vascular smooth muscle cell (VSMC) homeostasis. Endoplasmic reticulum (ER) stress is involved in the regulation of inflammation, oxidative stress and VSMC apoptosis, all of which are critical factors in AAA development. Although several studies have revealed the occurrence of ER stress in AAA development, the specific biological functions of ER stress in AAA development remain largely unknown. Given that targeting ER stress is a promising strategy for treating AAAs, further investigation of the physiological and pathological roles of ER stress in AAA development is warranted.

Keywords

Abdominal aortic aneurysm (AAA)
Endoplasmic reticulum (ER) stress
Vascular smooth muscle cell (VSMC)
Homeostasis
Inflammation
==== Body
pmc1 Introduction

Abdominal aortic aneurysms (AAAs) are characterized by progressive dilatation of the abdominal aorta and partial attenuation of the vessel structure [1]. Aortic rupture, which accounts for approximately 150,000–200,000 deaths worldwide each year, is the major risk factor associated with AAA [2]. AAA development is influenced by multiple mechanisms, including extracellular matrix (ECM) regression, inflammation, and vascular smooth muscle cell (VSMC) apoptosis [1], [3]. Emerging evidence has indicated that the development of AAA is often accompanied by endoplasmic reticulum (ER) stress. Hence, increase our understanding of the role of ER stress in AAA development is vital.

The ER is a multifunctional organelle that plays crucial roles in cellular protein trafficking, protein synthesis and folding [4], [5]. Various in vitro and in vivo factors may disrupt ER homeostasis, resulting in ER stress, which is characterized by the accumulation of unfolded and misfolded proteins [6], [7]. ER stress has been demonstrated to participate in pathophysiological processes of the cardiovascular system, including myocardial ischemia, atherosclerosis, and cardiomyopathy [8], [9], [10]. Emerging evidence suggests a link between ER stress and AAA development [11], [12]. Hence, further investigations into the functions of ER stress in AAA development is warranted.

In our review, we aim to provide an overview of recent knowledge about the involvement of ER stress in the pathological process of AAA development. We will specifically highlight the potential applications of targeting ER stress.

AAAs are characterized by permanent ectasia or bulging of the abdominal aorta [13]. The major cause of death among AAA patients is aortic rupture, with a reported prevalence of 4.4 per 100,000 patients [14]. It is estimated that the risk of AAA development increases as the diameter of the aorta increases. An AAA with a diameter less than 50 mm has an annual risk of rupture of less than 5 %, whereas an AAA with a diameter exceeding 80 mm has a 30–50 % annual risk of rupture [14], [15]. A history of long-term cigarette smoking is the strongest risk factor for AAA development, with smokers having a 5.9-fold higher risk of AAA development than nonsmokers [16], [17]. This association may be explained by the fact that toxic reactive compounds, such as acrolein, easily form protein adducts, which induces the unfolded protein response (UPR) and triggers ER stress. In addition, patients with cardiovascular disease associated with lipoperoxidation have a greater carbonyl burden, which can trigger ER stress [18], [19], [20], [21]. Other risk factors include advanced age, male sex, coronary artery disease (CAD), hypertension, and atherosclerosis in the coronary artery [22], [23], [24]. The pathogenic mechanisms underlying aortic aneurysm development include inflammatory responses, SMC apoptosis, oxidative stress, and ECM impairment, which contribute to aortic dilation and rupture [25], [26]. Several studies have investigated the role of ER stress and mitochondrial oxidative stress in the formation of AAAs [12].

2 ER stress and the UPR

The ER is a vital intracellular organelle that is involved in various cellular processes, including protein biosynthesis, folding, modification, calcium ion (Ca2+) storage, and lipid synthesis [27], [28]. Under certain physiological or pathological conditions, such as hypoxia, increased intracellular calcium levels, oxidative stress, inflammation, metabolic starvation, and glucose deficiency, the accumulation of unfolded and misfolded proteins leads to ER stress [29]. To resolve ER stress, the UPR is activated, which facilitates the transfer and removal of accumulated unfolded proteins during the early stages of ER stress [30]. The UPR triggers multiple signaling processes that promote protein folding, posttranslational modifications, and the restoration of ER homeostasis to alleviate ER stress [31], [32]. However, if the UPR fails to relieve prolonged or overwhelming ER stress, apoptosis is ultimately induced [33], [34].

The UPR involves three transmembrane proteins that are localized to the ER: inositol requiring enzyme-1 (IRE-1), protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), and activating transcription factor 6 (ATF6) [35]. Under normal physiological conditions, the immunoglobulin protein (BiP), which is also known as GRP78, prevents the activation of ATF6, PERK, and IRE1 by binding to them; this was first discovered in a mouse model of polycystic ovary syndrome (PCOS) following metformin treatment and the dihydrotestosterone (DHT)-mediated induction of ER stress [36]. However, when misfolded proteins accumulate, BiP binds to these proteins, releasing ATF6, PERK, and IRE1. These three transmembrane proteins coordinate the UPR and activate a broader gene expression program [37]. The activation of PERK during ER stress leads to the phosphorylation of eukaryotic initiation factor 2α (eIF2α), which results in a temporary reduction in overall protein translation, including that of ATF4, to alleviate the ER load [38]. On the other hand, persistent PERK activation by prolonged ER stress induces cell apoptosis through the C/EBP homologous protein (CHOP)/GADD153 pathway [39]. Additionally, once released from BiP, the endoribonuclease activity of IRE1 is increased via its dimerization and autophosphorylation, leading to the translation of X-box-binding protein 1 (XBP1) [40], [41]. XBP1 translocates to the nucleus and regulates protein folding, regression, and factors that are involved in redox equilibrium and the oxidative stress response, thereby mitigating the ER burden [42]. However, excessive and severe ER stress can lead to hyperactivation of IRE1 autophosphorylation, triggering maladaptive responses and cell death. Moreover, under ER stress conditions, ATF6 translocates to the Golgi apparatus, where it undergoes intramembrane cleavage mediated by site-1 protease (S1P) and site-2 protease (S2P), releasing the cytoplasmic portion of ATF6. The released and activated ATF6 then enters the nucleus and transactivates genes that encode UPR components, chaperones, ERAD components, and XBP1 [43], [44]. Under stress conditions, ATF6 activates genes that promote proper ER folding, eliminate misfolded proteins, restore redox homeostasis of the ER, and induce autophagy. These processes play important roles in maintaining cell viability. However, when the adaptive UPR fails to maintain ER homoeostasis, ATF6 promotes inflammation and apoptosis (Fig. 1) [45].Fig. 1 UPR and Inflammation mechanisms of ER stress in AAA.

Recent studies have demonstrated an increase in the expression of key ER stress markers, including XBP-1, cleaved ATF6, and CHOP, in AAAs [12]. 7-Ketocholesterol (7-KC) is an ER stress inducer, and its expression is related to the expression of ER stress markers. The regulation of 7-KC expression can regulate the ER stress level and mediate AAA progression [12], [25], [46]. On the other hand, ER stress inhibitors attenuate ER stress and significantly inhibit AAA development [25], [47]. These findings indicate that ER stress plays a significant role in AAA development. Therefore, suppression of ER stress has emerged as a potentially effective therapeutic strategy for preventing AAA formation and rupture [25], [48]. However, the precise mechanisms underlying the involvement of ER stress in AAA formation have yet to be fully elucidated. Further research is needed to elucidate the potential role of ER stress in AAA pathogenesis.

3 The contribution of ER stress to inflammation during AAA formation

Inflammatory cells are well known to produce inflammatory cytokines in response to tissue injury, and these cytokines can increase protein misfolding and trigger ER stress [49], [50]. The UPR is activated in affected tissues during various inflammatory diseases, including inflammatory bowel disease, neuromuscular inflammatory diseases and rheumatoid arthritis [50], [51].

The three UPR signaling pathways can also promote the expression of proinflammatory factors, such as MCP-1, TNF-α, and IL-8, which play crucial roles in the development of aortic aneurysms [47]. UPR activation is tightly interrelated with inflammatory signaling pathways, including the JNK and/or NF-κB signaling pathways, as well as potentially other pathways [52], [53]. JNK signaling regulates ECM metabolism by increasing MMP secretion and attenuating ECM biosynthesis during AAA formation [54], [55]. Several studies have shown that NF-κB promotes the expression of cytokines, such as MMP-1, MMP-3 and MMP-9, inducing AAA formation [56], [57]. ER stress-induced NF‐κB accumulation contributes to the formation of aortic aneurysms via the regulation of SMC phenotypes [58].

During ER stress, activated IRE1α triggers the adaptor protein TNF‐receptor activating factor 2, resulting in the retrogradation of the NF‐κB protein IκB kinase; this finding indicates an association between ER stress and NF‐κB activation [59]. This signaling pathway plays a crucial role in the regulation of numerous inflammatory pathways and has been reported to be a key player in AAA pathogenesis. Activated IRE1 also promotes important inflammatory pathways via activated JNK, thus integrating ER stress with other key signaling pathways that can regulate the transcription of various inflammatory cytokines [60]. Following ER stress and protein misfolding, the proteases S1P and S2P (site 1 and site 2) cleave ATF6 as it translocates from the ER to the Golgi, leading to the release of activated transcription factors and their translocation to the nucleus. The ATF6 pathway of the UPR has been reported to activate the NF-κB-IKK pathway, resulting in downstream AKT phosphorylation [61]. Furthermore, activated PERK, which inhibits protein translation by phosphorylating eIF2α in cells undergoing ER stress, leads to the upregulation of IκBα, which ultimately activates the NF‐κB signaling pathway(Fig. 1) [62].

4 VSMC development and ER stress in AAA-related diseases

VSMCs are the predominant cell type in the medial layer of the aorta, and they play crucial roles in maintaining vascular tone, strength, and elasticity by synthesizing various factors, such as elastin, collagen, laminin, and proteoglycans [62]. In the early stages of AAA development, the number of VSMCs in the medial layer of the arterial wall decreases. This depletion alters vascular tone and increases the susceptibility of the arterial wall to ectasia, ultimately resulting in aneurysm formation [26], [63]. Moreover, ER stress has been reported to promote severe VSMC apoptosis in human AAA tissues (Fig. 2) [64].Fig. 2 VSMC apoptosis mechanisms of ER stress in AAA.

5 The role of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) in AAA formation via the regulation of ER stress

SERCA is located on the SR membrane, and it plays a critical role in maintaining Ca2+ homeostasis [65]. The main function of SERCA is to transport cytosolic Ca2+ back into the SR lumen from the cytoplasm in response to muscle contraction [65], [66]. SERCA is a P-type ATPase, and it is an integral membrane protein of the SR/ER. It is encoded by three genes: ATP2A1, ATP2A2, and ATP2A3 [67]. SERCA1a is expressed predominantly in striated muscle cells, whereas SERCA2a is expressed mainly in cardiac muscle, smooth muscle, and nonmuscle tissues. SERCA2b is a ubiquitous isoform and serves as the housekeeping SERCA protein in muscle tissues, whereas SERCA3 is almost inactive in muscle tissues and is expressed at very low levels in nonmuscle cell types [68]. It has been reported that an irreversible oxidizing reaction of SERCA2 C674 contributes to the formation of aortic aneurysms by inducing ER stress and promoting SMC apoptosis [48]. Several studies have revealed that inactivation of SERCA2 C674 modulates SMC phenotypes due to intracellular Ca2+ accumulation, which triggers calcineurin-regulated NFAT/NF-κB signaling, thereby accelerating the development of aortic aneurysms(Fig. 3) [58], [69].Fig. 3 Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase2 mechanisms of ER stress in AAA.

6 ER stress-related targets of AAA formation

On the basis of evidence that indicates that ER stress is involved in the pathological process of AAA development, approaches that regulate factors related to ER homeostasis/UPR signaling are emerging as potential therapeutic approaches for treating AAAs. Alternative strategies that aim to enhance the adaptive UPR, which promotes cell survival and recovery, or suppress ER stress-associated apoptosis have shown promise in preventing AAA formation. The ER stress inhibitor tauroursodeoxycholic acid (TUDCA) has been reported to significantly inhibit Ang II-induced AAA development by attenuating ER stress-induced apoptosis [25]. Similarly, the ER stress inhibitor 4-PBA regulates BAPN-induced aortic aneurysm formation by inhibiting SMC apoptosis, ER stress, and inflammation. Thus, ER stress inhibitors show potential as treatments for aortic aneurysms [47]. TUDCA and 4-PBA have been found to exert many effects, including ER stress-modulatory, anti-apoptotic and anti-inflammatory effects, and they have potential therapeutic benefits in many diseases, such as AAAs, diabetes, obesity, neurodegenerative diseases, and cancer. However, the exact molecular pathways that are activated after treatment with these agents remain to be determined. Therefore, further extensive examination is still needed to reveal the novel roles of these inhibitors [70], [71], [72]. In addition, the EGFR inhibitor erlotinib has been shown to prevent Ang II-induced AAA formation by inhibiting EGFR protein aortic aneurysm formation, ER stress and oxidative stress responses [73]. The Cys674 residue (C674) in SERCA2 plays a vital role in maintaining the physiological functions of the ER. Oxidative inactivation of SERCA2 C674 exacerbates aortic aneurysm formation by promoting ER stress and subsequent SMC apoptosis and inflammation, suggesting that SERCA2 and ER stress are potential targets for treating aortic aneurysms [48]. Intermedin (IMD)1–53, which is a bioactive peptide, has been shown to prevent AAA development by inhibiting ER stress via the induction of AMPK phosphorylation. These findings provide novel insights for the development of potential therapeutic strategies for treating AAAs by targeting ER stress (Fig. 3) [65]. Additionally, a previous study demonstrated that silencing cav1 (caveolin 1) protects mice from AAA formation by preventing Ang II-induced ADAM17 activation/induction, ER stress, oxidative stress responses and inflammation [74]. These findings further support the notion that targeting ER stress could be a novel therapeutic approach for AAA development.

7 Conclusion

Emerging evidence indicates that ER stress and the UPR play key functions in the pathological processes of AAA formation. This evidence has been found primarily in AAA animal models; however, there are some differences between various AAA models and AAAs in humans. The most common approach for examining the mechanisms underlying AAA pathogenesis is the use of mouse and rat animal models. Three methods are commonly used to induce AAA development in animal models: angiotensin II infusion, elastase perfusion, and calcium chloride or phosphate administration. The angiotensin II-induced model typically involves suprarenal abdominal aortic aneurysms, which are different from the infrarenal abdominal aortic aneurysms that are common in humans. The typical features of this model are aortic dissection and intramural hematoma, which often rupture, leading to substantial differences between this model and human AAAs. However, the angiotensin II-induced model remains the most commonly studied AAA model. The elastase perfusion model typically involves infrarenal abdominal aortic aneurysms, which are similar to human AAAs. In contrast to human AAAs, elastase perfusion-induced AAAs do not rupture, and unlike the angiotensin II model, elastase perfusion-induced AAAs lead to expansion of the whole aortic wall. Compared with the other two models, the calcium chloride or phosphate model usually involves infrarenal abdominal aortic aneurysms, which have a relatively mild degree of aortic dilation. Moreover, this model has pathological features that are consistent with human AAAs, such as inflammation, angiogenesis, elastin rupture, and calcification, but this model also lacks some features of human AAAs, such as luminal thrombosis and aortic rupture [75], [76].

In this review, we aim to summarize the various ways in which ER stress contributes to AAA formation, including the UPR, inflammation, and SMC apoptosis. Although increasing evidence suggests the involvement of ER stress and the UPR in AAA formation, further research is needed to gain a deeper understanding of the mechanisms that drive these pathological processes. This knowledge will be invaluable for the development of more effective strategies for treating AAAs.

ER stress markers are early warning signs of impending AAA development and can be used to help prevent the occurrence of AAAs; however, there is currently insufficient evidence to prove this. GRP78 prevents the activation of ATF6, PERK, and IRE1 by binding to them [36]. However, GRP78 is a chaperone protein that is expressed mainly in the ER lumen, and it plays an important role in ER stress by assisting in the assembly of misfolded proteins and can translocate to the cell surface to initiate various intracellular pathways under certain conditions [77]. Masashi Miyao et al. reported that compared with those in healthy patients, 7-KC levels were significantly higher in the plasma of AAA patients. 7-KC levels are positively correlated with the vascular expression of ER stress markers in AAA patients, which contributes to AAA development. At present, ER stress markers have not been detected in circulating blood. 7-KC can reflect ER stress in AAA patients and is expected to be used a biomarker of ER stress and as an early warning sign imminent AAA formation [12], [78], [79].

Authors’ contributions

Z.X. and P.Z. designed the study and composed the manuscript. ZH.S. contributed to write the first version of manuscript. P.Z. corrected the manuscript for revision and finalized the manuscript. All authors read and approved the final manuscript.

Funding

This study was supported by Scientific Research Project of Ganzhou Municipal Health Commission (No. GZWJW202402303, to ZHS.).

Registration number of clinical studies

NA.

CRediT authorship contribution statement

Zhaohai Su: Writing – original draft, Investigation. Weiling Lu: Writing – original draft, Methodology. Jun Cao: Writing – original draft, Investigation. Zheng Xie: Writing – review & editing, Supervision. Pei Zhao: Writing – review & editing, Supervision.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgement

None.
==== Refs
References

1 Baman J.R. Eskandari M.K. What is an abdominal aortic aneurysm? J. Am. Med. Assoc. 328 22 2022 2280
2 Mortality G.B.D. Causes of Death C Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 9963 2015 117 171 25530442
3 Pinard A. Jones G.T. Milewicz D.M. Genetics of thoracic and abdominal aortic diseases Circ. Res. 124 4 2019 588 606 30763214
4 Omidkhoda N. Wallace Hayes A. Reiter R.J. Karimi G. The role of MicroRNAs on endoplasmic reticulum stress in myocardial ischemia and cardiac hypertrophy Pharmacol. Res. 150 2019 104516
5 Shakeri A. Zirak M.R. Wallace Hayes A. Reiter R. Karimi G. Curcumin and its analogues protect from endoplasmic reticulum stress: Mechanisms and pathways Pharmacol. Res. 146 2019 104335
6 Wang L. Chen J. Ning C. Lei D. Ren J. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic fatty liver disease (NAFLD) Curr. Drug Targets 19 9 2018 1087 1094 29766802
7 Diaz-Bulnes P. Saiz M.L. Lopez-Larrea C. Rodriguez R.M. Crosstalk between hypoxia and ER stress response: a key regulator of macrophage polarization Front. Immunol. 10 2019 2951 31998288
8 Yang S. Wu M. Li X. Zhao R. Zhao Y. Liu L. Role of endoplasmic reticulum stress in atherosclerosis and its potential as a therapeutic target Oxid. Med. Cell. Longev. 2020 2020 9270107 32963706
9 Zhu H. Zhou H. Novel insight into the role of endoplasmic reticulum stress in the pathogenesis of myocardial ischemia-reperfusion injury Oxid. Med. Cell. Longev. 2021 2021 5529810 33854692
10 Zhang Y. Sowers J.R. Ren J. Targeting autophagy in obesity: from pathophysiology to management Nat. Rev. Endocrinol. 14 6 2018 356 376 29686432
11 Li Y. Lu G. Sun D. Zuo H. Wang D.W. Yan J. Inhibition of endoplasmic reticulum stress signaling pathway: a new mechanism of statins to suppress the development of abdominal aortic aneurysm PLoS One 12 4 2017 e0174821 28369137
12 Navas-Madronal M. Rodriguez C. Kassan M. Fite J. Escudero J.R. Canes L. Enhanced endoplasmic reticulum and mitochondrial stress in abdominal aortic aneurysm Clin. Sci. 133 13 2019 1421 1438
13 Li Y. Maegdefessel L. Non-coding RNA contribution to thoracic and abdominal aortic aneurysm disease development and progression Front. Physiol. 8 2017 429 28670289
14 Benjamin E.J. Virani S.S. Callaway C.W. Chamberlain A.M. Chang A.R. Cheng S. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association Circulation 137 12 2018 e67 e492 29386200
15 Chaikof E.L. Dalman R.L. Eskandari M.K. Jackson B.M. Lee W.A. Mansour M.A. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm J. Vasc. Surg. 67 1 2018 2 77 e2 29268916
16 Lederle F.A. Nelson D.B. Joseph A.M. Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review J. Vasc. Surg. 38 2 2003 329 334 12891116
17 Lederle F.A. Johnson G.R. Wilson S.E. Chute E.P. Littooy F.N. Bandyk D. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group Ann. Intern. Med. 126 6 1997 441 449 9072929
18 Soppert J. Lehrke M. Marx N. Jankowski J. Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting Adv. Drug Deliv. Rev. 159 2020 4 33 32730849
19 Hauck A.K. Huang Y. Hertzel A.V. Bernlohr D.A. Adipose oxidative stress and protein carbonylation J. Biol. Chem. 294 4 2019 1083 1088 30563836
20 Gianazza E. Brioschi M. Fernandez A.M. Banfi C. Lipoxidation in cardiovascular diseases Redox Biology. 23 2019 101119
21 Negre-Salvayre A. Garoby-Salom S. Swiader A. Rouahi M. Pucelle M. Salvayre R. Proatherogenic effects of 4-hydroxynonenal Free Radic. Biol. Med. 111 2017 127 139 28040472
22 Hernesniemi J.A. Vanni V. Hakala T. The prevalence of abdominal aortic aneurysm is consistently high among patients with coronary artery disease J. Vasc. Surg. 62 1 2015 232 40 e3 26115925
23 Kent K.C. Zwolak R.M. Egorova N.N. Riles T.S. Manganaro A. Moskowitz A.J. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals J. Vasc. Surg. 52 3 2010 539 548 20630687
24 Toghill B.J. Saratzis A. Bown M.J. Abdominal aortic aneurysm-an independent disease to atherosclerosis? Cardiovasc. Pathol. 27 2017 71 75 28189002
25 Qin Y. Wang Y. Liu O. Jia L. Fang W. Du J. Tauroursodeoxycholic acid attenuates angiotensin II induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice by inhibiting endoplasmic reticulum stress Eur. J. Vascular Endovascular Surg. : Off. J. Eur. Soc. Vascular Surg. 53 3 2017 337 345
26 Lopez-Candales A. Holmes D.R. Liao S. Scott M.J. Wickline S.A. Thompson R.W. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms Am. J. Pathol. 150 3 1997 993 1007 9060837
27 Schwarz D.S. Blower M.D. The endoplasmic reticulum: structure, function and response to cellular signaling Cell. Mol. Life Sci. 73 1 2016 79 94 26433683
28 Lau E. Lee C. Li B. Pierro A. Endoplasmic reticulum stress in the acute intestinal epithelial injury of necrotizing enterocolitis Pediatr. Surg. Int. 37 9 2021 1151 1160 34117913
29 Hetz C. Zhang K. Kaufman R.J. Mechanisms, regulation and functions of the unfolded protein response Nat. Rev. Mol. Cell Biol. 21 8 2020 421 438 32457508
30 Xia S.W. Wang Z.M. Sun S.M. Su Y. Li Z.H. Shao J.J. Endoplasmic reticulum stress and protein degradation in chronic liver disease Pharmacol. Res. 161 2020 105218
31 Hotamisligil G.S. Endoplasmic reticulum stress and atherosclerosis Nat. Med. 16 4 2010 396 399 20376052
32 Adachi Y. Yamamoto K. Okada T. Yoshida H. Harada A. Mori K. ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum Cell Struct. Funct. 33 1 2008 75 89 18360008
33 Ajoolabady A. Wang S. Kroemer G. Klionsky D.J. Uversky V.N. Sowers J.R. ER stress in cardiometabolic diseases: from molecular mechanisms to therapeutics Endocr. Rev. 42 6 2021 839 871 33693711
34 Ren J. Bi Y. Sowers J.R. Hetz C. Zhang Y. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases Nat. Rev. Cardiol. 18 7 2021 499 521 33619348
35 Oakes S.A. Endoplasmic reticulum stress signaling in cancer cells Am. J. Pathol. 190 5 2020 934 946 32112719
36 Zhang C. Roles of Grp78 in female mammalian reproduction Adv. Anat. Embryol. Cell Biol. 222 2017 129 155 28389754
37 Gregersen N. Bross P. Protein misfolding and cellular stress: an overview Methods Mol. Biol. 648 2010 3 23 20700702
38 Harding H.P. Zhang Y. Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase Nature 397 6716 1999 271 274 9930704
39 Hu H. Tian M. Ding C. Yu S. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection Front. Immunol. 9 2018 3083 30662442
40 Minamino T. Kitakaze M. ER stress in cardiovascular disease J. Mol. Cell. Cardiol. 48 6 2010 1105 1110 19913545
41 Lee K. Tirasophon W. Shen X. Michalak M. Prywes R. Okada T. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response Genes Dev. 16 4 2002 452 466 11850408
42 Lee A.H. Iwakoshi N.N. Glimcher L.H. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response Mol. Cell Biol. 23 21 2003 7448 7459 14559994
43 Yamamoto K. Sato T. Matsui T. Sato M. Okada T. Yoshida H. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1 Dev. Cell 13 3 2007 365 376 17765680
44 Wu J. Rutkowski D.T. Dubois M. Swathirajan J. Saunders T. Wang J. ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress Dev. Cell 13 3 2007 351 364 17765679
45 Sharma R.B. Snyder J.T. Alonso L.C. Atf6alpha impacts cell number by influencing survival, death and proliferation Mol. Metab. 27S Suppl. 2019 S69 S80 31500833
46 Miyao M. Cicalese S. Cooper H.A. Eguchi S. Endoplasmic reticulum stress and mitochondrial biogenesis are potential therapeutic targets for abdominal aortic aneurysm Clin. Sci. 133 19 2019 2023 2028
47 Jia L.X. Zhang W.M. Li T.T. Liu Y. Piao C.M. Ma Y.C. ER stress dependent microparticles derived from smooth muscle cells promote endothelial dysfunction during thoracic aortic aneurysm and dissection Clin. Sci. 131 12 2017 1287 1299
48 Wang L. Yang Z. Wang S. Que Y. Shu X. Wu F. Substitution of SERCA2 Cys(674) accelerates aortic aneurysm by inducing endoplasmic reticulum stress and promoting cell apoptosis Br. J. Pharmacol. 179 17 2022 4423 4439 35491240
49 Martinon F. Chen X. Lee A.H. Glimcher L.H. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages Nat. Immunol. 11 5 2010 411 418 20351694
50 Hasnain S.Z. Lourie R. Das I. Chen A.C. McGuckin M.A. The interplay between endoplasmic reticulum stress and inflammation Immunol. Cell Biol. 90 3 2012 260 270 22249202
51 Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 6 2010 900 917 20303879
52 Brenner C. Galluzzi L. Kepp O. Kroemer G. Decoding cell death signals in liver inflammation J. Hepatol. 59 3 2013 583 594 23567086
53 Duwaerts C.C. Maher J.J. Mechanisms of liver injury in non-alcoholic steatohepatitis Curr. Hepatol. Rep. 13 2 2014 119 129 25045618
54 Wang Y. Jia L. Xie Y. Cai Z. Liu Z. Shen J. Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development Atherosclerosis 289 2019 64 72 31479773
55 Yoshimura K. Aoki H. Ikeda Y. Furutani A. Hamano K. Matsuzaki M. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice Ann. N. Y. Acad. Sci. 1085 2006 74 81 17182924
56 Ramella M. Boccafoschi F. Bellofatto K. Follenzi A. Fusaro L. Boldorini R. Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA) Am. J. Transl. Res. 9 12 2017 5485 5495 29312500
57 Qiu Z. Chen L. Cao H. Chen Q. Peng H. Mechanical strain induced expression of matrix metalloproteinase-9 via stretch-activated channels in rat abdominal aortic dissection Med. Sci. Monit. 23 2017 1268 1276 28286334
58 Que Y. Shu X. Wang L. Wang S. Li S. Hu P. Inactivation of SERCA2 Cys(674) accelerates aortic aneurysms by suppressing PPARgamma Br. J. Pharmacol. 178 11 2021 2305 2323 33591571
59 Hayakawa K. Nakajima S. Hiramatsu N. Okamura M. Huang T. Saito Y. ER stress depresses NF-kappaB activation in mesangial cells through preferential induction of C/EBP beta J. Am. Soc. Nephrol. 21 1 2010 73 81 19875812
60 Urano F. Wang X. Bertolotti A. Zhang Y. Chung P. Harding H.P. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1 Science 287 5453 2000 664 666 10650002
61 Yamazaki H. Hiramatsu N. Hayakawa K. Tagawa Y. Okamura M. Ogata R. Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response J. Immunol. 183 2 2009 1480 1487 19561103
62 Deng J. Lu P.D. Zhang Y. Scheuner D. Kaufman R.J. Sonenberg N. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2 Mol. Cell Biol. 24 23 2004 10161 10168 15542827
63 Ailawadi G. Moehle C.W. Pei H. Walton S.P. Yang Z. Kron I.L. Smooth muscle phenotypic modulation is an early event in aortic aneurysms J. Thorac. Cardiovasc. Surg. 138 6 2009 1392 1399 19931668
64 Ni X.Q. Lu W.W. Zhang J.S. Zhu Q. Ren J.L. Yu Y.R. Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO Mice Endocrine 62 1 2018 90 106 29943223
65 Toyoshima C. Structural aspects of ion pumping by Ca2+-ATPase of sarcoplasmic reticulum Arch. Biochem. Biophys. 476 1 2008 3 11 18455499
66 Vandecaetsbeek I. Trekels M. De Maeyer M. Ceulemans H. Lescrinier E. Raeymaekers L. Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump PNAS 106 44 2009 18533 18538 19846779
67 Hovnanian A. SERCA pumps and human diseases Subcell. Biochem. 45 2007 337 363 18193643
68 Periasamy M. Maurya S.K. Sahoo S.K. Singh S. Sahoo S.K. Reis F.C.G. Role of SERCA pump in muscle thermogenesis and metabolism Compr. Physiol. 7 3 2017 879 890 28640447
69 Que Y. Shu X. Wang L. Hu P. Wang S. Xiong R. Inactivation of cysteine 674 in the SERCA2 accelerates experimental aortic aneurysm J. Mol. Cell. Cardiol. 139 2020 213 224 32035136
70 Kusaczuk M. Tauroursodeoxycholate-bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives Cells 8 12 2019
71 Kolb P.S. Ayaub E.A. Zhou W. Yum V. Dickhout J.G. Ask K. The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis Int. J. Biochem. Cell Biol. 61 2015 45 52 25660369
72 Xiong Y. Wang Y. Xiong Y. Teng L. 4-PBA inhibits hypoxia-induced lipolysis in rat adipose tissue and lipid accumulation in the liver through regulating ER stress Food Sci. Nutr. 11 3 2023 1223 1231 36911831
73 Obama T. Tsuji T. Kobayashi T. Fukuda Y. Takayanagi T. Taro Y. Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model Clin. Sci. (Lond.) 128 9 2015 559 565 25531554
74 Takayanagi T. Crawford K.J. Kobayashi T. Obama T. Tsuji T. Elliott K.J. Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase Clin. Sci. (Lond.) 126 11 2014 785 794 24329494
75 Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments Nat. Rev. Cardiol. 16 4 2019 225 242 30443031
76 Golledge J. Krishna S.M. Wang Y. Mouse models for abdominal aortic aneurysm Br. J. Pharmacol. 179 5 2022 792 810 32914434
77 Akinyemi A.O. Simpson K.E. Oyelere S.F. Nur M. Ngule C.M. Owoyemi B.C.D. Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review Mol. Med. 29 1 2023 112 37605113
78 Lin P. Chen F. Yang Y. Song Y. Li X. Lan X. GRP78 expression and immunohistochemical localization in the female reproductive tract of mice Theriogenology 78 8 2012 1824 1829 22968032
79 Ibrahim I.M. Abdelmalek D.H. Elfiky A.A. GRP78: A cell's response to stress Life Sci. 226 2019 156 163 30978349
